In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis
- 30 June 1987
- journal article
- research article
- Published by Elsevier BV in Tubercle
- Vol. 68 (2), 113-118
- https://doi.org/10.1016/0041-3879(87)90026-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.The Journal of Antibiotics, 1981
- Binding of rifampicin by human plasma proteinsEuropean Journal of Clinical Pharmacology, 1974
- Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research CouncilTubercle, 1973
- A Selective Oleic Acid Albumin Agar Medium For Tubercle BacilliJournal of Medical Microbiology, 1972
- Laboratory aspects of intermittent drug therapyPublished by Oxford University Press (OUP) ,1971
- Suitability of rifampicin for intermittent administration in the treatment of tuberculosisTubercle, 1970
- In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosisTubercle, 1966